pharma news today obesity drugs glp-1 september 2025 Eli Lilly set to leapfrog Novo Nordisk in weight-loss drug race GLP-1 medications like Ozempic, Wegovy

[DOI] [PMC free article] [PubMed] [Google Scholar] 108.Zhu M., Ackerman J.J., Sukstanskii A.L., Yablonskiy D.A

Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy

How Does Tirzepatide Work and Its Benefits Tirzepatide, a dual GLP-1/GIP receptor agonist, is an innovative injectable treatment that addresses weight loss effectively by mimicking natural hormonesGLP-1 and GIPthat regulate appetite and blood sugar

doi: 10.1016/j.autrev.2009.11.014 10 BasuBRChowdhuryOSahaSK

The effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress